Anemia
News from the FDA/CDC
FDA approves Givlaari for treatment of acute hepatic porphyria
Prior to this approval, existing treatments provided only partial relief from porphyria attacks, according to the FDA.
News from the FDA/CDC
FDA approves treatment for sickle cell pain crises
Crizanlizumab-tmca (Adakveo) is approved for patients with sickle cell disease who are aged 16 years and older.
News from the FDA/CDC
FDA approves anemia treatment for transfusion-dependent beta thalassemia patients
Luspatercept-aamt (Reblozyl) is approved for adults with beta thalassemia who require regular red blood cell transfusions.
Conference Coverage
Best practice alerts really can work
SAN ANTONIO – A majority of alerts triggered by red blood cell orders were overridden, but for sound clinical reasons, investigators found.
Feature
NIH seeks gene-based cures for HIV, sickle cell disease
The agency is collaborating with the Bill & Melinda Gates Foundation for the $200 million, 4-year project.
Clinical Review
Autoimmune Hemolytic Anemia: Evaluation and Diagnosis
Clinical Review
Autoimmune Hemolytic Anemia: Treatment of Common Types
Feature
Readmission burden high for those with sickle cell disease
SCD more than doubles the risk of 30-day readmission, compared with non-SCD stays.
From the Journals
In older patients with immune-mediated TTP, atypical features may delay diagnosis
Thrombocytopenia with anemia should alert physicians to this possible rare diagnosis in older patients with nonspecific neurological abnormalities...
News
FDA approves afamelanotide for treatment of rare condition with light-induced pain
This is the first treatment approved to help patients with erythropoietic protoporphyria increase their exposure to light.
Feature
Hypoxia-related discoveries net Nobel Prize
A trio of physician scientists have won the Nobel Prize for their work, which has implications for the treatment of anemia, cancer, and other...